>>Gardasil for males is going to be a tough sell for MRK when they present their case to the third-party payers.
This question might display my ignorance. :-(
Would Gardasil use by males reduce their acquiring and transmitting the HPV? (I would think that to be the case and be part of the sales pitch. Seems if you can cut the transmission rate that is very good. One active male could do a lot.) :-)
I'm quite certain Cervarix will be recommended for reimbursement for the prevention of cervical cancer in women, by ACIP but doubt the committee will find Gardasil for the prevention of genital warts in males, cost effective.
Market Data 
Markets 
AI
